{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:41:35Z","timestamp":1787244095933,"version":"build-2736575974"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Insurance System"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Failure of artemisinin-based combination therapy is increasingly reported in patients with Plasmodium falciparum malaria in sub-Saharan Africa. We aimed to describe the clinical and genomic characteristics of recent cases of P. falciparum malaria failing artemether-lumefantrine in Belgium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Travel-related cases of malaria confirmed at the national reference laboratory of the Institute of Tropical Medicine, Antwerp, Belgium, were reviewed. All cases for which attending clinicians reported persistence (beyond Day 3 post-treatment initiation, i.e. early failure) or recrudescence (from Day 7 to 42, i.e. late failure) of P. falciparum parasites despite adequate drug intake were analysed. Both initial and persistent\/recurrent samples were submitted to next generation sequencing to investigate resistance-conferring mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From July 2022 to June 2023, eight P. falciparum cases of failure with artemether-lumefantrine therapy were reported (early failure\u2009=\u20091; late failure\u2009=\u20097). All travellers were returning from sub-Saharan Africa, most (6\/8) after a trip to visit friends and relatives. PfKelch13 (PF3D7_1343700) mutations associated with resistance to artemisinin were found in two travellers returning from East Africa, including the validated marker R561H in the patient with early failure and the candidate marker A675V in a patient with late failure. Additional mutations were detected that could contribute to decreased susceptibility to artemisinin in another three cases, lumefantrine in six cases and proguanil in all eight participants. Various regimens were used to treat the persistent\/recrudescent cases, with favourable outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Within a 12-month period, we investigated eight travellers returning from sub-Saharan Africa with P. falciparum malaria and in whom artemether-lumefantrine failure was documented. Mutations conferring resistance to antimalarials were found in all analysed blood samples, especially against lumefantrine and proguanil, but also artemisinin. There is a pressing need for systematic genomic surveillance of resistance to antimalarials in international travellers with P. falciparum malaria, especially those experiencing treatment failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jtm\/taad165","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T11:07:04Z","timestamp":1703329624000},"source":"Crossref","is-referenced-by-count":13,"title":["Failure of artemether-lumefantrine therapy in travellers returning to Belgium with\n                    <i>Plasmodium falciparum<\/i>\n                    malaria: an observational case series with genomic analysis"],"prefix":"10.1093","volume":"31","author":[{"given":"Jan","family":"Pierreux","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles , Brussels 1000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bottieau","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Florence","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Infectious Diseases, University Hospital of Antwerp , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ula","family":"Maniewski","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bruggemans","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiska","family":"Malotaux","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital , Ghent 9000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8995-6230","authenticated-orcid":false,"given":"Charlotte","family":"Martin","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles , Brussels 1000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Immunity, Jessa Hospital , Hasselt 3500 , Belgium"},{"name":"Faculty of Medicine and Life Sciences, University of Hasselt , Hasselt 3500 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Konopnicki","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles , Brussels 1000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Guetens","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Verschueren","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Coppens","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Van Esbroeck","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathijs","family":"Mutsaers","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rosanas-Urgell","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Institute of Tropical Medicine , Antwerp 2000 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"2024040613362681000_ref1","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1016\/j.lanepe.2020.100001","article-title":"Travel-related infections presenting in Europe: a 20-year analysis of Eurotravnet surveillance data","volume":"1","author":"Grobusch","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2024040613362681000_ref2","doi-asserted-by":"crossref","first-page":"taac002","DOI":"10.1093\/jtm\/taac002","article-title":"Causes of fever in returning travelers: a European multicenter prospective cohort study","volume":"29","author":"Camprub\u00ed-Ferrer","year":"2022","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref3","volume-title":"ECDC. Annual Epidemiological Report for 2021","author":"European Centre for Disease Prevention and Control","year":"2023"},{"key":"2024040613362681000_ref4","volume-title":"WHO Guidelines for Malaria, 14 March 2023","author":"WHO","year":"2023"},{"key":"2024040613362681000_ref5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1473-3099(17)30524-8","article-title":"Spread of a single multidrug resistant malaria parasite lineage (Pfpailin) to Vietnam","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2024040613362681000_ref6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMe2110659","article-title":"Emergence of artemisinin-resistant Plasmodium falciparum in East Africa","volume":"385","author":"White","year":"2021","journal-title":"N Engl J Med"},{"key":"2024040613362681000_ref7","volume-title":"Methods for Surveillance of Antimalarial Drug Efficacy","author":"WHO","year":"2009"},{"key":"2024040613362681000_ref8","doi-asserted-by":"crossref","first-page":"taad036","DOI":"10.1093\/jtm\/taad036","article-title":"Weight-related malaria treatment failure with artemether\u2013lumefantrine","volume":"30","author":"Halani","year":"2023","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2024040613362681000_ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","article-title":"Association of mutations in the Plasmodium falciparum kelch13 gene (pf3d7_1343700) with parasite clearance rates after artemisinin-based treatments\u2014a WWARN individual patient data meta-analysis","volume":"17","author":"Amaratunga","year":"2019","journal-title":"BMC Med"},{"key":"2024040613362681000_ref11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"2024040613362681000_ref12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in Southeast Asia: a genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2024040613362681000_ref13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"2024040613362681000_ref14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N Engl J Med"},{"key":"2024040613362681000_ref15","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1073\/pnas.1812317115","article-title":"Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility","volume":"115","author":"Demas","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024040613362681000_ref16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpddr.2021.05.007","article-title":"Plasmodium falciparum resistance to acts: emergence, mechanisms, and outlook","volume":"16","author":"Siddiqui","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2024040613362681000_ref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2019.101505","article-title":"Imported malaria and artemisinin-based combination therapy failure in travellers returning to Belgium: a retrospective study","volume":"32","author":"Rovira-Vallbona","year":"2019","journal-title":"Travel Med Infect Dis"},{"key":"2024040613362681000_ref18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/cid\/ciw710","article-title":"High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series","volume":"64","author":"Sond\u00e9n","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024040613362681000_ref19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02382-16","article-title":"Pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the United Kingdom","volume":"61","author":"Sutherland","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2024040613362681000_ref20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1469-0691.2010.03344.x","article-title":"Validation of a four-primer real-time PCR as a diagnostic tool for single and mixed Plasmodium infections","volume":"17","author":"Cnops","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2024040613362681000_ref21","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.16.2100724","article-title":"Two fatal autochthonous cases of airport malaria, Belgium, 2020","volume":"27","author":"Van Bortel","year":"2022","journal-title":"Euro Surveill"},{"key":"2024040613362681000_ref22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","article-title":"Malaria","volume":"391","author":"Ashley","year":"2018","journal-title":"Lancet"},{"key":"2024040613362681000_ref23","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad001","article-title":"Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers","volume":"30","author":"Kurth","year":"2023","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2014-02-555953","article-title":"Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins","volume":"124","author":"Jaur\u00e9guiberry","year":"2014","journal-title":"Blood"},{"key":"2024040613362681000_ref25","doi-asserted-by":"crossref","first-page":"e0096022","DOI":"10.1128\/spectrum.00960-22","article-title":"Malaria molecular surveillance in the Peruvian Amazon with a novel highly multiplexed Plasmodium falciparum AmpliSeq assay","volume":"11","author":"Kattenberg","year":"2023","journal-title":"Microbiol Spectr"},{"key":"2024040613362681000_ref26","doi-asserted-by":"crossref","first-page":"e4621","DOI":"10.21769\/BioProtoc.4621","article-title":"Molecular surveillance of malaria using the PF AmpliSeq custom assay for Plasmodium falciparum parasites from dried blood spot DNA isolates from Peru","volume":"13","author":"Kattenberg","year":"2023","journal-title":"Bio Protoc"},{"key":"2024040613362681000_ref27","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","article-title":"Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site","volume":"44","author":"Korsinczky","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2024040613362681000_ref28","volume-title":"Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010\u20132019)","author":"WHO","year":"2020"},{"key":"2024040613362681000_ref29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1021\/acsinfecdis.9b00527","article-title":"Plasmodium falciparum artemisinin resistance: the effect of Heme, protein damage, and parasite cell stress response","volume":"6","author":"Rosenthal","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2024040613362681000_ref30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/pharmaceutics13081273","article-title":"Prevalence of mutations in the Pfcoronin gene and association with ex vivo susceptibility to common Quinoline drugs against Plasmodium falciparum","volume":"13","author":"Delandre","year":"2021","journal-title":"Pharmaceutics"},{"key":"2024040613362681000_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taad114","article-title":"Emergence of artemisinin-based combination treatment failure in patients returning from sub-Saharan Africa with P. falciparum malaria","volume":"30","author":"Grossman","year":"2023","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116057","article-title":"Selection of Pfcrt k76 and Pfmdr1 N86 coding alleles after uncomplicated malaria treatment by artemether-lumefantrine in Mali","volume":"22","author":"Maiga","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024040613362681000_ref33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/dkx431","article-title":"Clinical implications of Plasmodium resistance to atovaquone\/proguanil: a systematic review and meta-analysis","volume":"73","author":"Staines","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024040613362681000_ref34","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac061","article-title":"The impact of the COVID-19 pandemic on malaria in returning travellers in Canada: a retrospective population-based cohort study","volume":"29","author":"Lieu","year":"2022","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref35","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac083","article-title":"Trends in imported malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network)","volume":"29","author":"Norman","year":"2022","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref36","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac116","article-title":"Increased imported severe Plasmodium falciparum malaria involving hyperparasitaemia (&gt;10%) in a UK hospital following relaxation of COVID-19 restrictions compared to the pre-pandemic period","volume":"29","author":"Choy","year":"2022","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref37","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab046","article-title":"Trends of the global, regional and national incidence of malaria in 204 countries from 1990 to 2019 and implications for malaria prevention","volume":"28","author":"Liu","year":"2021","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref38","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac078","article-title":"Malaria in sub-Saharan Africa-a continuing risk for international travellers","volume":"29","author":"Huits","year":"2022","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12936-017-1711-5","article-title":"Increase in imported malaria in the Netherlands in asylum seekers and VFR travellers","volume":"16","author":"Gier","year":"2017","journal-title":"Malar J"},{"key":"2024040613362681000_ref40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","article-title":"Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda","volume":"223","author":"Asua","year":"2021","journal-title":"J Infect Dis"},{"key":"2024040613362681000_ref41","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/cid\/ciac162","article-title":"Circulation of an artemisinin-resistant malaria lineage in a traveler returning from East Africa to France","volume":"75","author":"Copp\u00e9e","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024040613362681000_ref42","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac092","article-title":"The first case of artemisinin treatment failure of Plasmodium falciparum imported to Oman from Tanzania","volume":"30","author":"Subudhi","year":"2023","journal-title":"J Travel Med"},{"key":"2024040613362681000_ref43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12936-021-03859-z","article-title":"Decreased prevalence of the Plasmodium falciparum Pfcrt k76t and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete district, Eastern Zambia","volume":"20","author":"Mulenga","year":"2021","journal-title":"Malar J"},{"key":"2024040613362681000_ref44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12936-015-0850-9","article-title":"Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker Pfcrt-76 13 years after cessation of chloroquine use in Msambweni, Kenya","volume":"14","author":"Kiarie","year":"2015","journal-title":"Malaria J"},{"key":"2024040613362681000_ref45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1475-2875-13-244","article-title":"Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia","volume":"13","author":"Mekonnen","year":"2014","journal-title":"Malar J"},{"key":"2024040613362681000_ref46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13104-019-4269-1","article-title":"High prevalence of Pfmdr-1 N86 and D1246 genotypes detected among febrile malaria outpatients attending Lira Regional Referral Hospital, Northern Uganda","volume":"12","author":"Achol","year":"2019","journal-title":"BMC Res Notes"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taad165\/56269584\/taad165.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/31\/3\/taad165\/57174588\/taad165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/31\/3\/taad165\/57174588\/taad165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T09:36:54Z","timestamp":1712396214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taad165\/7503849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12,29]]},"published-print":{"date-parts":[[2024,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taad165","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2023,12,29]]},"article-number":"taad165"}}